Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Outcome Between Oral Methotrexate and Tofacitinib in Treatment of Chronic Plaque Psoriasis

NCT07581418 is registered in ClinicalTrials.gov with Pak Emirates Military Hospital as lead sponsor.

NCT NCT07581418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07581418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Outcome Between Oral Methotrexate and Tofacitinib in Treatment of Chronic Plaque Psoriasis
Lead sponsor
Pak Emirates Military Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
December 1, 2026
Enrollment
88 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic plaque psoriasis